JOSEPH REDDICK: Open Payments
NPI 1750521936 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 20 payments from 11 companies in 2025. Trend: 2023 $137 · 2024 $187 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| PFIZER INC. | 3 | $61 |
| Corcept Therapeutics | 3 | $51 |
| Antares Pharma, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, Korlym, NURTEC ODT, XYOSTED, JARDIANCE, GARDASIL 9, ELIQUIS, NEXLETOL.
Industry payments across FL — which companies pay providers there.
